Susan Kelliher - Chemours President
| CC Stock | MXN 408.90 0.00 0.00% |
President
Ms. Susan M. Kelliher is Senior Vice President Human Resources and Health Services of the company. Ms. Kelliher joined Chemours in 2017 from Albemarle Corporation, where she served as Senior Vice President Human Resources for the global specialty chemical company. Prior to Albemarle, she served as Vice President Human Resources at Hewlett Packard, where she held a number of leadership positions on global teams including Imaging and Printing and Global Sales and Enterprise Marketing from 2007 to 2012. Before joining Hewlett Packard, Ms. Kelliher served as Vice President Human Resources for Cymer, Inc., where she led the people function. She joined Cymer from The Home Depot where, from 2004 to 2007, she was the Vice President Human Resources for the growth engines of the company Business Development and Home Services including responsibility for due diligence and integration for the companys acquisitions. From 2000 to 2004, Ms. Kelliher served as Senior Director of Human Resources for Corporationrationrate Business Development and International Operations for the Raytheon Company . Prior to Raytheon, she served as the Director of Human Resources Western Region for YUM Brands, Pizza Hut division from 1995 to 2000. Ms. Kelliher started her career at Mobil Oil, where her career progressed through a variety of assignments including support for new ventures in Europe, Russia, and Africa from 1990 to 1995. since 2017.
| Age | 56 |
| Tenure | 7 years |
| Phone | 302 773 1000 |
| Web | https://www.chemours.com |
Chemours Management Efficiency
The company has return on total asset (ROA) of 0.0653 % which means that it generated a profit of $0.0653 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.5281 %, meaning that it generated $0.5281 on every $100 dollars invested by stockholders. Chemours' management efficiency ratios could be used to measure how well Chemours manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 3 records | PRESIDENT Age | ||
| Robert Telesmanic | Cognizant Technology Solutions | 56 | |
| William Deckelman | DXC Technology | 65 | |
| Srinivasan Veeraraghavachary | Cognizant Technology Solutions | 63 | |
Management Performance
| Return On Equity | 0.53 | |||
| Return On Asset | 0.0653 |
Chemours Leadership Team
Elected by the shareholders, the Chemours' board of directors comprises two types of representatives: Chemours inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Chemours. The board's role is to monitor Chemours' management team and ensure that shareholders' interests are well served. Chemours' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Chemours' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Mark Newman, CFO, Senior Vice President | ||
| Edwin Sparks, President - Chemical Solutions | ||
| Jonathan Lock, Sr Officer | ||
| Kurt Bonner, Ma Relations | ||
| Kristine Wellman, Gen VP | ||
| Alisha Bellezza, Director of Investor Relations | ||
| Sameer Ralhan, CFO, Senior Vice President Treasurer | ||
| Susan Kelliher, Senior Vice President – Human Resources and Health Services | ||
| Camela Wisel, Chief VP | ||
| Alvenia Scarborough, Sr Officer |
Chemours Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Chemours a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.53 | |||
| Return On Asset | 0.0653 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.12 % | |||
| Current Valuation | 146.34 B | |||
| Shares Outstanding | 148.5 M | |||
| Shares Owned By Insiders | 1.09 % | |||
| Shares Owned By Institutions | 77.77 % | |||
| Price To Earning | 82.94 X | |||
| Price To Book | 3.61 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Chemours Stock Analysis
When running Chemours' price analysis, check to measure Chemours' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Chemours is operating at the current time. Most of Chemours' value examination focuses on studying past and present price action to predict the probability of Chemours' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Chemours' price. Additionally, you may evaluate how the addition of Chemours to your portfolios can decrease your overall portfolio volatility.